Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
about
Nicotiana benthamiana as a production platform for artemisinin precursorsPlant-based oral vaccines against zoonotic and non-zoonotic diseasesPutting the Spotlight Back on Plant Suspension CulturesPlant-made oral vaccines against human infectious diseases-Are we there yet?Reconstitution of the costunolide biosynthetic pathway in yeast and Nicotiana benthamianaExpression of recombinant cellulase Cel5A from Trichoderma reesei in tobacco plantsAn interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccinesPlant-made vaccines in support of the Millennium Development Goals.Automated production of plant-based vaccines and pharmaceuticals.Development of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells.NanoUPLC-MSE proteomic data assessment of soybean seeds using the Uniprot databaseIsoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity.CYP98A22, a phenolic ester 3'-hydroxylase specialized in the synthesis of chlorogenic acid, as a new tool for enhancing the furanocoumarin concentration in Ruta graveolens.High-level transient expression of ER-targeted human interleukin 6 in Nicotiana benthamianaExpression and subcellular targeting of human complement factor C5a in Nicotiana speciesProtein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins.Cloning and Expression of TNF Related Apoptosis Inducing Ligand in Nicotiana tabacum.Assessing the bioconfinement potential of a Nicotiana hybrid platform for use in plant molecular farming applications.SNP-based genetic linkage map of tobacco (Nicotiana tabacum L.) using next-generation RAD sequencingChloroplasts as expression platforms for plant-produced vaccines.Strategies for the plant-based expression of dengue subunit vaccines.Combinatorial biosynthesis in plants: a (p)review on its potential and future exploitation.Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.Stable mitotic inheritance of rice minichromosomes in cell suspension cultures.M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.Co-expression of hepatitis C virus polytope-HBsAg and p19-silencing suppressor protein in tobacco leaves.Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.Detection and expression analysis of recombinant proteins in plant-derived complex mixtures using nanoUPLC-MS(E).Evaluation of somatic embryos of alfalfa for recombinant protein expression.Comparison of VHH-Fc antibody production in Arabidopsis thaliana, Nicotiana benthamiana and Pichia pastoris.The development, characterization, and demonstration of a novel strategy for purification of recombinant proteins expressed in plants.High-yield expression of recombinant soybean agglutinin in plants using transient and stable systems.Transgenic tobacco plants as production platform for biologically active human interleukin 2 and its fusion with proteinase inhibitors
P2860
Q21562149-6B4C3C47-F26D-426E-B8F2-17344F32646FQ26738581-4AA48AA8-8C70-4A1D-9F39-4623B08805BBQ26750974-A310DE73-69DC-4FCF-9148-DE177D8B37F0Q26783111-34EBE677-E221-46B3-80E7-F5F9C8E1E95EQ28476550-C55B932F-A97E-4481-93F8-6B90B74AE718Q28654891-E5E2DCC6-ECB4-46DB-9401-73E7BFD514EFQ28730453-CA742A2D-A966-4A07-963A-872C9C28EBFCQ30396217-EC6F4883-DEBA-4BDA-BC63-E4B71A4846D8Q30421674-B05E9A5A-249D-4560-9011-14CD389230A1Q30425644-49EC3FEA-D1E9-4FF5-84D1-B14243ABFCB5Q30576122-1751BC43-59DD-419A-981C-775A91309639Q33668899-551F1F8A-4349-42E5-B218-246EE94B0776Q34397279-C85BBA50-0E17-4F53-950E-FFA5324422BCQ34477570-AE678CEA-1DCD-4FF3-9F26-476F07A75344Q34534970-E383757F-B115-47A5-9794-BF4C902A1495Q34714768-15297A98-73EC-4CD7-B2AC-8D02904C157EQ34777770-AAC0D4BE-BD56-4B18-BF26-C5A358643326Q34892567-05A45F1E-7101-422A-BA00-DD52F0A33AC5Q35809898-2549665A-2A1C-485B-919F-D3217F9567EBQ37776719-CDD99442-6142-4FD6-8137-E9E443C7043CQ37812659-D8A09AAD-0E97-45F8-9170-4FD20387BB41Q37939609-A26CAFAF-4033-4211-B156-4267BA6BFC7DQ38174581-73E0D476-D945-4C17-9C89-87B6287374ABQ38232409-B3968BA9-2D50-4148-B02A-95AAE36F9F69Q38914280-ED93DFF3-8A50-45CA-BB7A-0E6A363535A3Q40263958-4CFCF5B1-7AB0-4C07-9664-8716449AA42EQ40922357-7527BD0D-0FF7-49D9-97A8-E0229BB037C0Q41365905-546D868F-3956-489E-A785-CBE7288564E7Q43499161-A06F0117-B8F0-4C64-B733-31E235D228B3Q44916488-AEFE7648-B85C-45F5-B05C-2FF9E12303AAQ46811880-F3795862-73C8-470C-B5F5-7252FE5307FFQ49160630-1347040F-561C-45C1-B141-9C30459ABFA0Q50525791-514178B4-6DDF-4062-AAF2-F6815286D47BQ50574557-9E51774C-12D3-4598-B52B-8D6A8147F79EQ57661822-7D517EE2-93C6-4A05-8C1B-DA28A1D09FA0
P2860
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@en
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@nl
type
label
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@en
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@nl
prefLabel
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@en
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@nl
P2093
P1476
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins.
@en
P2093
Anthony M Jevnikar
David Wang
Reynald Tremblay
Shengwu Ma
P304
P356
10.1016/J.BIOTECHADV.2009.11.008
P577
2009-12-02T00:00:00Z